Bromide

Bromide

SCHEMBL3576597

Br.O=C1CN2C=CC=CC2=N1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 4/20 0.37
HPGD P15428 3/20 0.37
POLB P06746 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
KMT2A Q03164 1/20 0.37
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL892819 0.98 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDPOLBHSD17B10
Hydrochloric Acid SCHEMBL3306488 0.96 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDPOLBHSD17B10
Pentane SCHEMBL28765480 0.86 ALDH1A1 (0.33) ALDH1A1KDM4EHPGDPOLBHSD17B10
SCHEMBL11326257 0.78 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDPOLBHSD17B10
SCHEMBL2162391 0.78 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDPOLBHSD17B10
SCHEMBL3457997 0.72 KDM4E (0.38) ALDH1A1KDM4EHPGDPOLBHSD17B10
SCHEMBL10028948 0.72 KDM4E (0.38) ALDH1A1KDM4EHPGDPOLBHSD17B10
SCHEMBL2230323 0.72 ALDH1A1 (0.30) ALDH1A1HPGDHSD17B10
SCHEMBL15805618 0.70 KDM4E (0.36) ALDH1A1KDM4EHPGD
SCHEMBL15966901 0.69 KDM4E (0.30) ALDH1A1KDM4EPOLBGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074121-B1 CHYMASE INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2016-11-30 EP disclosed
US-8193214-B2 Chymase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-05 US disclosed
US-20100029637-A1 Chymase Inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-02-04 US disclosed
EP-2074121-A1 CHYMASE INHIBITORS Boehringer Ingelheim International GmbH (DE) 2009-07-01 EP disclosed
WO-2008045688-A1 CHYMASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-04-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029637-A1 Chymase Inhibitors CMA1, CPA3, SERPINB1 ALDH1A1 3399/4885KDM4E 3782/4885HPGD 1813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.